These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16421458)

  • 41. Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia.
    Li KY; Li X; Cheng ZN; Zhang BK; Peng WX; Li HD
    Eur J Clin Pharmacol; 2005 Jan; 60(11):791-5. PubMed ID: 15599502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of quetiapine in the treatment of bipolar disorder.
    Pini S; Abelli M; Cassano GB
    Expert Opin Pharmacother; 2006 May; 7(7):929-40. PubMed ID: 16634715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quetiapine Excretion Into Human Breast Milk.
    Yazdani-Brojeni P; Tanoshima R; Taguchi N; Garcia-Bournissen F; Wallach I; Moretti ME; Verjee Z; Ito S
    J Clin Psychopharmacol; 2018 Aug; 38(4):362-364. PubMed ID: 29912789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F; Pesa J; Wang RH
    J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.
    Gjestad C; Haslemo T; Andreassen OA; Molden E
    Br J Clin Pharmacol; 2017 Nov; 83(11):2398-2405. PubMed ID: 28585378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine: a review of its safety in the management of schizophrenia.
    Dev V; Raniwalla J
    Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
    Emsley RA; Raniwalla J; Bailey PJ; Jones AM
    Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term use of quetiapine in elderly patients with psychotic disorders.
    Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
    Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
    Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
    J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
    Pérez-Iglesias R; Ortiz-Garcia de la Foz V; Martínez García O; Amado JA; Garcia-Unzueta MT; Ayesa-Arriola R; Suarez-Pinilla P; Tabares-Seisdedos R; Crespo-Facorro B
    Schizophr Res; 2014 Oct; 159(1):90-4. PubMed ID: 25151200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection.
    Davis PC; Wong J; Gefvert O
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):271-82. PubMed ID: 10704032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quetiapine for acute mania in bipolar disorder.
    Brahm NC; Gutierres SL; Carnahan RM
    Am J Health Syst Pharm; 2007 May; 64(10):1045-53. PubMed ID: 17494904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.